Sema4 and BioSymetrics partner on drug discovery in cardiovascular, rare and neurological diseases Feb. 23, 2022 No Comments
Chinese researchers divulge 5-HT2AR antagonists and/or melatonin MT1 and/or MT2 receptor agonists Feb. 22, 2022 No Comments
Alkem signs license agreement with Harvard for technology to treat vascular disease Feb. 11, 2022 No Comments
Praxis Precision Medicines discovers potassium channel subfamily T member 1 inhibitors Feb. 4, 2022 No Comments
DDO-02005, a novel potent Kv1.5 potassium channel inhibitor with antiarrhythmic activity Feb. 1, 2022 No Comments
RSS